(Q39583199)

13 September 2017

title

The use of an impeded androgen--danazol--in the management of benign breast disorders (English)

1 reference

13 September 2017

R H Asch

1

1 reference

13 September 2017

R B Greenblatt

series ordinal

2

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 January 1977

1 reference

American Journal of Obstetrics and Gynecology

13 September 2017

published in

1 reference

13 September 2017

volume

127

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

130-134

1 reference

Carcinoma of the breast during estrogen replacement therapy

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2933237-9

Biological basis for management of benign disease of the breast. The case against subcutaneous mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2933237-9

Malignant and benign human mammary disease: estrogen binding in relation to clinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2933237-9

Clinical Studies with an Antigonadotropin-Danazol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2933237-9

10.1016/S0002-9378(16)33237-9

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference